Based on previous studies, we can hypothesize that Bcl2l1 may be upregulated in response to the adverse effects of a high glucose environment on the myocardium in patients with diabetes, as a reactive mechanism to resist these effects. This evidence concerns the gene BCL2L1 and diabetes mellitus.